CoreValve, S.A. Comments on Alleged Patent Infringement Action by Edwards Lifesciences

IRVINE, Calif.--(BUSINESS WIRE)--CoreValve has been informed of recent legal action by Edwards Lifesciences in the courts in Germany. CoreValve believes that the lawsuit filed by Edwards is without merit and the company intends to vigorously defend its own intellectual property and its right to continue to develop and clinically evaluate its proprietary ReValving™ System for the less invasive treatment of patients with advanced aortic valve disease.